Annotations: 2FHW

Chains	Polymer	Molecular Function	Biological Process	Cellular Component
A [auth B]	Relaxin 3 (Prorelaxin H3) (Insulin-like peptide INSL7) (Insulin-like peptide 7)	protein binding binding signaling receptor binding G protein-coupled receptor binding hormone activity molecular function activator activity molecular function regulator activity signaling receptor regulator activity receptor ligand activity signaling receptor activator activity	-	extracellular region cellular anatomical entity
B [auth A]	Relaxin 3 (Prorelaxin H3) (Insulin-like peptide INSL7) (Insulin-like peptide 7)	protein binding binding signaling receptor binding G protein-coupled receptor binding hormone activity molecular function activator activity molecular function regulator activity signaling receptor regulator activity receptor ligand activity signaling receptor activator activity	-	extracellular region cellular anatomical entity

Chains	Accession	Name	Type
A [auth B]	IPR051777	Insulin-like_neuropeptide_ligands	Family
A [auth B]	IPR022352	Insulin family	Family
A [auth B]	IPR022353	Insulin, conserved site	Conserved Site
A [auth B]	IPR036438	Insulin-like superfamily	Homologous Superfamily
A [auth B]	IPR016179	Insulin-like	Domain
B [auth A]	IPR051777	Insulin-like_neuropeptide_ligands	Family
B [auth A]	IPR022352	Insulin family	Family
B [auth A]	IPR022353	Insulin, conserved site	Conserved Site
B [auth A]	IPR036438	Insulin-like superfamily	Homologous Superfamily
B [auth A]	IPR016179	Insulin-like	Domain

Chains	Drug Target	Associated Disease
A [auth B]	Pharos: Q8WXF3	hyperplasia coronary artery disease myocardial ischemia
B [auth A]	Pharos: Q8WXF3	hyperplasia coronary artery disease myocardial ischemia